TG Therapeutics | TGTX - Ebitda





Ebitda Veränderung Datum
AbbVie USD 3.69B 1.68B 2026-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Amgen USD 3.86B 1.28B 2026-03
Ardelyx USD -29.77M 35.79M 2026-03
Arrowhead Research USD -147.68M 40.33M 2026-06
Bayer EUR 2.14B 2.31B 2026-06
Biogen USD 649.7M 76.5M 2026-03
Corcept Therapeutics USD -49M 53.2M 2026-03
Curis USD -12.3M 231K 2023-09
Gilead Sciences USD 3.51B 489M 2026-03
J&J USD 8.27B 1.08B 2026-03
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Novartis USD 6.48B 1.19B 2026-06
Novavax USD 19.36M 190.79M 2025-12
PTC Therapeutics USD 61.98M 132.97M 2026-03
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
TG Therapeutics USD 26.9M 1.21M 2026-06
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06